Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
Bokemeyer
C
C
Schmoll
H J
HJ
Kuczyk
M A
MA
Beyer
J
J
Siegert
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D005047:Etoposide